Bhas 42 cell transformation activity of cigarette smoke condensate is modulated by selenium and arsenic

Environmental and Molecular Mutagenesis

Volumn 57, Issue 3, 2016, Pages 220-228

  Han, Sung Gu ^a   Pant, Kamala ^b   Bruce, Shannon W ^b   Gairola, C Gary ^c  

^a Konkuk University   (South Korea)

^b BioReliance Corporation   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Arsenic; Bhas 42 cells; Cell transformation; Cigarette smoke condensate; Selenium; Tumorigenesis

Indexed keywords

ARSENIC; CIGARETTE SMOKE CONDENSATE; SELENIUM; TUMOR PROMOTER; DIMETHYL SULFOXIDE;

ARTICLE; BHAS 42 CELL; CARCINOGENESIS; CELL ASSAY; CELL CULTURE; CELL TRANSFORMATION; CELLS; CYTOTOXICITY; MODULATION; OXIDATIVE STRESS; ADVERSE EFFECTS; ANIMAL; CARCINOGEN TESTING; CHEMISTRY; DOSE RESPONSE; DRUG EFFECTS; MOUSE; PROCEDURES; SMOKING; TOXICITY TESTING; TRANSFORMED CELL LINE;

ANIMALS; ARSENIC; CARCINOGENICITY TESTS; CELL LINE, TRANSFORMED; CELL TRANSFORMATION, NEOPLASTIC; DIMETHYL SULFOXIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; MICE; SELENIUM; SMOKING; TOXICITY TESTS;

EID: 84960444701     PISSN: 08936692     EISSN: 10982280     Source Type: Journal    
DOI: 10.1002/em.22000     Document Type: Article

References (48)

1. Ansong E, Yang W, Diamond AM. 2014. Molecular cross-talk between members of distinct families of selenium containing proteins. Mol Nutr Food Res 58:117-123.
2. Asada S, Sasaki K, Tanaka N, Takeda K, Hayashi M, Umeda M. 2005. Detection of initiating as well as promoting activity of chemicals by a novel cell transformation assay using v-Ha-ras-transfected BALB/c 3T3 cells (Bhas 42 cells). Mutat Res 588:7-21.
3. Benigni R. 2012. Alternatives to the carcinogenicity bioassay for toxicity prediction: Are we there yet? Expert Opin Drug Metab Toxicol 8:407-417.
4. Bhalla DK, Hirata F, Rishi AK, Gairola CG. 2009. Cigarette smoke, inflammation, and lung injury: A mechanistic perspective. J Toxicol Environ Health B Crit Rev 12:45-64.
5. Bhattacharjee P, Banerjee M, Giri AK. 2013. Role of genomic instability in arsenic-induced carcinogenicity: A review. Environ Int 53:29-40.
6. Bock FG. 1972. Tumor promoters in tobacco and cigarette-smoke condensate. J Natl Cancer Inst 48:1849-1853.
7. Bogden JD, Kemp FW, Buse M, Thind IS, Louria DB, Forgacs J, Llanos G, Moncoya Terrones I. 1981. Composition of tobaccos from countries with high and low incidences of lung cancer. I. Selenium, polonium-210, Alternaria, tar, and nicotine. J Natl Cancer Inst 66:27-31.
8. Bustaffa E, Stoccoro A, Bianchi F, Migliore L. 2014. Genotoxic and epigenetic mechanisms in arsenic carcinogenicity. Arch Toxicol 88:1043-1067.
9. CDC. 2010. How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease: A report of the Surgeon General. Service PH, translator. Rockville, MD: U.S. Department of Health and Human Resources.
10. Christian WJ, Huang B, Rinehart J, Hopenhayn C. 2011. Exploring geographic variation in lung cancer incidence in Kentucky using a spatial scan statistic: Elevated risk in the Appalachian coal-mining region. Public Health Rep 126:789-796.
11. Church DF, Pryor WA. 1985. Free-radical chemistry of cigarette smoke and its toxicological implications. Environ Health Perspect 64:111-126.
12. Clark LC, Combs GF Jr., Turnbull BW, Slate EH, Chalker DK, Chow J, Davis LS, Glover RA, Graham GF, Gross EG, et al. 1996. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA 276:1957-1963.
13. Coggins CR, McKinney WJ Jr, Oldham MJ. 2013. A comprehensive evaluation of the toxicology of experimental, non-filtered cigarettes manufactured with different circumferences. Inhal Toxicol 25 (Suppl 2):69-72.
14. Creton S, Aardema MJ, Carmichael PL, Harvey JS, Martin FL, Newbold RF, O'Donovan MR, Pant K, Poth A, Sakai A, et al. 2012. Cell transformation assays for prediction of carcinogenic potential: State of the science and future research needs. Mutagenesis 27:93-101.
15. DeMarini DM. 2004. Genotoxicity of tobacco smoke and tobacco smoke condensate: A review. Mutat Res 567:447-474.
16. Dittrich DJ, Fieblekorn RT, Bevan MJ, Rushforth D, Murphy JJ, Ashley M, McAdam KG, Liu C, Proctor CJ. 2014. Approaches for the design of reduced toxicant emission cigarettes. Springerplus 3:374.
17. Ghadi FE, Malhotra A, Ghara AR, Dhawan DK. 2012. Selenium as a modulator of membrane stability parameters and surface changes during the initiation phase of 1, 2-dimethylhydrazine induced colorectal carcinogenesis. Mol Cell Biochem 369:119-126.
18. Glauert HP, Martin JB, Li J, Tharappel JC, Han SG, Gillespie HD, Cantor AH, Lee EY, Gairola CG. 2013. Dietary selenium fails to influence cigarette smoke-induced lung tumorigenesis in A/J mice. Cancer Lett 334:127-132.
19. Hecht SS. 1999. Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst 91:1194-1210.
20. Hoffmann D, Hoffmann I, El-Bayoumy K. 2001. The less harmful cigarette: A controversial issue. A tribute to Ernst L. Wynder. Chem Res Toxicol 14:767-790.
21. IARC. 2004. Tobacco Smoke and Involuntary Smoking. France: Lyon.
22. Jayaprakash V, Marshall JR. 2011. Selenium and other antioxidants for chemoprevention of gastrointestinal cancers. Best Pract Res Clin Gastroenterol 25:507-518.
23. Johnson N, Shelton BJ, Hopenhayn C, Tucker TT, Unrine JM, Huang B, Christian W, Zhang Z, Shi X, Li L. 2011. Concentrations of arsenic, chromium, and nickel in toenail samples from Appalachian Kentucky residents. J Environ Pathol Toxicol Oncol 30:213-223.
24. Kitchin KT. 2001. Recent advances in arsenic carcinogenesis: Modes of action, animal model systems, and methylated arsenic metabolites. Toxicol Appl Pharmacol 172:249-261.
25. Li J, Tharappel JC, Han SG, Cantor AH, Lee EY, Gairola CG, Glauert HP. 2009. Effect of dietary selenium and cigarette smoke on pulmonary cell proliferation in mice. Toxicol Sci 111:247-253.
26. Lowe FJ, Luettich K, Gregg EO. 2013. Lung cancer biomarkers for the assessment of modified risk tobacco products: An oxidative stress perspective. Biomarkers 18:183-195.
27. Martins-Green M, Adhami N, Frankos M, Valdez M, Goodwin B, Lyubovitsky J, Dhall S, Garcia M, Egiebor I, Martinez B, et al. 2014. Cigarette smoke toxins deposited on surfaces: Implications for human health. PLoS One 9:e86391.
28. Moktar A, Ravoori S, Vadhanam MV, Gairola CG, Gupta RC. 2009. Cigarette smoke-induced DNA damage and repair detected by the comet assay in HPV-transformed cervical cells. Int J Oncol 35:1297-1304.
29. Muramatsu D, Sasaki K, Kuroda S, Hayashi K, Tanaka N, Sakai A. 2009. Comparison of sensitivity to arsenic compounds between a Bhas 42 cell transformation assay and a BALB/c 3T3 cell transformation assay. Mutat Res 675:66-70.
30. Ohmori K, Sasaki K, Asada S, Tanaka N, Umeda M. 2004. An assay method for the prediction of tumor promoting potential of chemicals by the use of Bhas 42 cells. Mutat Res 557:191-202.
31. Pryor WA, Prier DG, Church DF. 1983. Electron-spin resonance study of mainstream and sidestream cigarette smoke: Nature of the free radicals in gas-phase smoke and in cigarette tar. Environ Health Perspect 47:345-355.
32. Reszka E. 2012. Selenoproteins in bladder cancer. Clin Chim Acta 413:847-854.
33. Reuter S, Gupta SC, Chaturvedi MM, Aggarwal BB. 2010. Oxidative stress, inflammation, and cancer: How are they linked? Free Radic Biol Med 49:1603-1616.
34. Roemer E, Schramke H, Weiler H, Buettner A, Kausche S, Weber S, Berges A, Stueber M, Muench M, Trelles-Sticken E, et al. 2012. Mainstream smoke chemistry and in vitro and in vivo toxicity of the reference cigarettes 3R4F. Beitrage Zur Tabakforschung Int Contributions Tobacco Res 25:316-335.
35. Sakai A, Sasaki K, Hayashi K, Muramatsu D, Arai S, Endou N, Kuroda S, Poth A, Bohnenberger S, Kunkelmann T, et al. 2011. An international validation study of a Bhas 42 cell transformation assay for the prediction of chemical carcinogenicity. Mutat Res 725:57-77.
36. Sakai A, Sasaki K, Muramatsu D, Arai S, Endou N, Kuroda S, Hayashi K, Lim YM, Yamazaki S, Umeda M, et al. 2010. A Bhas 42 cell transformation assay on 98 chemicals: The characteristics and performance for the prediction of chemical carcinogenicity. Mutat Res 702:100-122.
37. Sakai A, Suzuki C, Masui Y, Kuramashi A, Takatori K, Tanaka N. 2007. The activities of mycotoxins derived from Fusarium and related substances in a short-term transformation assay using v-Ha-ras-transfected BALB/3T3 cells (Bhas 42 cells). Mutat Res 630:103-111.
38. Sasaki K, Mizusawa H, Ishidate M. 1988. Isolation and characterization of ras-transfected BALB/3T3 clone showing morphological transformation by 12-O-tetradecanoyl-phorbol-13-acetate. Jpn J Cancer Res 79:921-930.
39. Sasaki K, Umeda M, Sakai A, Yamazaki S, Tanaka N. 2015. Transformation assay in Bhas 42 cells: A model using initiated cells to study mechanisms of carcinogenesis and predict carcinogenic potential of chemicals. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 33:1-35.
40. Schumacher JN, Green CR, Best FW, Newell MP. 1977. Smoke composition. An extensive investigation of the water-soluble portion of cigarette smoke. J Agric Food Chem 25:310-320.
41. Smith CJ, Perfetti TA, King JA. 2006. Perspectives on pulmonary inflammation and lung cancer risk in cigarette smokers. Inhal Toxicol 18:667-677.
42. Thirunavukkarasu C, Babu E, Ebrahim AS, Chandramohan N, Sakthisekaran D. 2004. Antioxidant-associated chemoprevention by sodium selenite in N-nitrosodiethylamine-induced and phenobarbital-promoted hepatocarcinogenesis in rats. Cell Biochem Funct 22:265-271.
43. U.S. Food and Drug Administration. 2009. Division A-Family smoking prevention and tobacco control act. Public Law, 111, pp. 31. Available at: http://www.fda.gov/TobaccoProducts/GuidanceComplianceRegulatoryInformation/ucm237092.htm.
44. USDHHS. 2010. How Tobacco Smoke Causes Diseases: The Biology and Behavioral Basis for Smoking-Attributable Disease. Atlanta, GA: U.S. Department of Health and Human Services.
45. Valavanidis A, Vlachogianni T, Fiotakis K. 2009. Tobacco smoke: Involvement of reactive oxygen species and stable free radicals in mechanisms of oxidative damage, carcinogenesis and synergistic effects with other respirable particles. Int J Environ Res Public Health 6:445-462.
46. Weisensee D, Poth A, Roemer E, Conroy LL, Schlage WK. 2013. Cigarette smoke-induced morphological transformation of Bhas 42 cells in vitro. Altern Lab Anim 41:181-189.
47. Wynder EL, Hoffmann D. 1967. Tobacco and Tobacco Smoke. Studies in Experimental Carcinogenesis. New York: Academic Press. pp 225-231.
48. Zang LY, Stone K, Pryor WA. 1995. Detection of free radicals in aqueous extracts of cigarette tar by electron spin resonance. Free Radic Biol Med 19:161-167. Accepted by S. Galloway.